Companies Dominating the Osmotic Laxative Market
- GlaxoSmithKline
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bayer AG
- Pfizer Inc.
- Sanofi
- Johnson & Johnson Private Limited
- Novartis AG
- Procter & Gamble
- Reckitt Benckiser Group PLC
- Boehringer Ingelheim International GmbH
- AstraZeneca
Browse Key Market Insights with Data Illustration:
In the News
- Together, Bayer AG and Peking University (PKU) will accelerate scientific research on cutting-edge technologies throughout the pharmaceutical value chain and support the translation of fundamental pharmaceutical research into drug discovery and development.
- The U.S. subsidiary of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, and Sanofi have announced a partnership to co-develop and co-commercialize asset TEV’574, which is presently undergoing Phase 2b clinical trials for the treatment of Crohn’s disease and ulcerative colitis, two forms of inflammatory bowel disease.
